Pfizer Announces Phase 3 Results of Investigational Compound Bosutinib
|
06 December 2010 |
Pfizer Launches Global Centers for Therapeutic Innovation
|
18 November 2010 |
Adding INSPRA® (eplerenone) to Standard Therapy Significantly Reduces the Risk of CV Mortality and Morbidity
|
15 November 2010 |
Alpine Mountaineer and Alzheimer's Advocate to Climb Highest Peak on Each Continent
|
09 November 2010 |
Pfizer Reports Third-Quarter 2010 Revenues of $16.2 Billion
|
03 November 2010 |
Patients With ALK-Positive Advanced Non-Small Cell Lung Cancer Responded to Crizotinib (PF-02341066)
|
28 October 2010 |
Pfizer Enters Into Agreement to Acquire 40 Percent Stake in Teuto in Brazil
|
22 October 2010 |
Biocon and Pfizer Enter Into Global Commercialization Agreement
|
20 October 2010 |
Results from a national survey of Alzheimer's Disease
|
15 October 2010 |
Pfizer to Acquire King Pharmaceuticals, Inc.
|
13 October 2010 |
Updated Pfizer Pipeline Focuses on Value, Unmet Medical Need
|
28 September 2010 |
Pfizer Commended For Leadership In Addressing Climate Change
|
22 September 2010 |
Pfizer to Acquire FoldRx Pharmaceuticals
|
02 September 2010 |
World Health Organization Grants Prequalification to Prevenar 13
|
24 August 2010 |
Pfizer Reports Second-Quarter 2010 Results
|
11 August 2010 |
Pfizer to Offer Free Public Access to Mental Health Assessment Tools
|
23 July 2010 |
Pfizer Strengthens Manufacturing Capabilities in Asia
|
13 July 2010 |
Pfizer Suspends Tanezumab Osteoarthritis Clinical Trial Program
|
25 June 2010 |
Phase 3 Study Showed MACUGEN® Improved Vision Over Standard of Care
|
07 June 2010 |
Pfizer Global Manufacturing Announces Plans to Reconfigure its Global Plant Network
|
20 May 2010 |